DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.39
-0.36 (-5.33%)
Aug 28, 2026, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $344.59 million as of August 31, 2026. Its market cap has increased by 11.48% in one year.
Market Cap
344.59M
Enterprise Value
301.27M
1-Year Change
11.48%
Ranking
Category
Stock Price
$6.39
ChartMarket Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $344.59M, an increase of 838.92%. That is a compound annual growth rate of 33.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 344.60M | -16.86% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 366.42M |
| Zentalis Pharmaceuticals | 359.75M |
| Foghorn Therapeutics | 356.31M |
| Lyell Immunopharma | 356.06M |
| Palisade Bio | 348.54M |
| Agenus | 344.86M |
| SAB Biotherapeutics | 344.84M |
| Sutro Biopharma | 339.08M |